NRXP Stock Discussion
NeuroRx, Inc. Description
NeuroRx, Inc. operates as a clinical stage-small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders. Its drug candidate includes Cyclurad, an oral therapeutic for the treatment of acute/elevated suicidal ideation/crisis in bipolar depression. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Industry: Conglomerates
Keywords: Life Sciences Health Sciences Health Care Central Nervous System Disorders Antidepressants Bipolar Disorder Treatment Of Central Nervous System Disorders Atypical Antipsychotics Bipolar Depression
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles